BMJ June 27, 2022
Stephen H Bradley, clinical research fellow, Scott Hemphill, resident medical officer, emergency medicine, Sarah Markham, visiting researcher, Shivan Sivakumar, clinical career development fellow

Stephen Bradley and colleagues call for action to ensure equitable returns for patients and taxpayers when public healthcare data are shared for commercial research

The threats to patient privacy from sharing data have been well publicised. By comparison, the risks of healthcare systems missing out on the gains generated from healthcare data have been largely overlooked. As well as potential benefits from improved treatment or diagnosis, research using patient data can bring financial rewards—for example, by selling artificial intelligence (AI) products the data are used to develop. The indicative market value of the data held by England’s NHS has been estimated at £5bn if it were to be sold for commercial purposes.1

For cash strapped healthcare systems, stewardship...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Big Data, Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID, Technology
The Ripple Effect: Ways to Make Health in All Policies Stick in Kansas and Beyond to Enhance Health and Equity
Research Funding Is Needed To Support An Effective, Equitable, And Sustainable Public Health System
Covid’s scientific silver lining: A chance to watch the human immune system respond in real time
New Data: Long COVID Cases Surge
New federal health IT strategy increases focus on public health, AI

Share This Article